Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Complications of atherosclerosis are the most common cause of death in Western societies. Among the many risk factors identified by epidemiological studies, only elevated levels of lipoproteins containing apolipoprotein (apo) B can drive the development of atherosclerosis in humans and experimental animals even in the absence of other risk factors. However, the mechanisms that lead to atherosclerosis are still poorly understood. We tested the hypothesis that the subendothelial retention of atherogenic apoB-containing lipoproteins is the initiating event in atherogenesis. The extracellular matrix of the subendothelium, particularly proteoglycans, is thought to play a major role in the retention of atherogenic lipoproteins. The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycans. Here we present direct experimental evidence that the atherogenicity of apoB-containing low-density lipoproteins (LDL) is linked to their affinity for artery wall proteoglycans. Mice expressing proteoglycan-binding-defective LDL developed significantly less atherosclerosis than mice expressing wild-type control LDL. We conclude that subendothelial retention of apoB100-containing lipoprotein is an early step in atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated concentration of low-density lipoprotein enhances its retention under the arterial wall(17); retention and oxidation of low-density lipoprotein are fundamental events in atherogenesis.(18)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [18]
In the citing paper
“The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans (particularly chondroitin sulphate of biglycan and versican and heparin sulphate of perlecan 110 ) with positively charged apolipoproteins (especially apolipoprotein B) , which leads to the retention of plasma-derived lipoproteins 101,111 - as”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [101]
In the citing paper
“the interaction of apoB-containing lipoproteins (the non-HDL lipoproteins) with intimal extracellular proteoglycans (referred to as retention)1,43,44 inhibits the movement of the lipoproteins, thereby resulting in much higher subendothelial concentrations of these lipoproteins in the intima than in any other tissue45.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [44]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
A simple fluorometric assay for lipoperoxide in blood plasma
Yagi, K. (1976) · Biochemical Medicine · doi:10.1016/0006-2944(76)90049-1 · Cited by 2,103 · cited 1×
“The concentrations of thiobarbituric-acid-reactive substance”
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003 · cited 1×
“gif" NDATA ITEM> ]> Complications of atherosclerosis are the most common cause of death in Western societie”
BackgroundTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Self-citationBorén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · cited 1×
“The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycan”
BackgroundSelf-citationImmunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti, A., Kaveri, S., Caligiuri, G., Bariéty, J., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119892 · Cited by 301
Cited by
Items 201–300 of 1,000
Witztum, J. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26130 · Cited by 81
Jagavelu, K., Tietge, U. J. F., Gaestel, M., Drexler, H., Schieffer, B., & Bavendiek, U. (2007) · Circulation Research · doi:10.1161/circresaha.107.156075 · Cited by 90
Immunology of ischemic vascular disease: plaque to attack
Hallenbeck, J. M., Hansson, G. K., & Becker, K. J. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.007 · Cited by 87
The small leucine‐rich repeat proteoglycans in tissue repair and atherosclerosis
Hultgårdh‐Nilsson, A., Borén, J., & Chakravarti, S. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12400 · Cited by 76
Self-citationLi, A. C., & Palinski, W. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141247 · Cited by 86
Monocytes and macrophages as protagonists in vascular complications of diabetes
Kanter, J. E., Hsu, C.-C., & Bornfeldt, K. E. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00010 · Cited by 76
“Initially, monocytes enter the subendothelial space in susceptible arteries in response to the retention of apolipoprotein B (APOB)-containing lipoproteins (25), which bind through positive charges in APOB to negatively charged extracellular matrix molecules, primarily glycosaminoglycans (26).”
BackgroundBeijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice
Chen, T., Jia, G., Wei, Y., & Li, J. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.09.004 · Cited by 82
Serum Amyloid A Is an Exchangeable Apolipoprotein
Wilson, P. G., Thompson, J. C., Shridas, P., McNamara, P. J., de Beer, M. C., de Beer, F. C., Webb, N. R., & Tannock, L. R. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310979 · Cited by 81
Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke
CASLAKE, M. J., & Packard, C. J. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0321 · Cited by 77
Mechanism of lipoprotein retention by the extracellular matrix
Gustafsson, M., & Borén, J. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200410000-00003 · Cited by 75
Self-citationImmune Mechanisms in Cardiovascular Diseases Associated With Viral Infection
Gopal, R., Marinelli, M. A., & Alcorn, J. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570681 · Cited by 80
Singh, R. K., Haka, A. S., Asmal, A., Barbosa-Lorenzi, V. C., Grosheva, I., Chin, H. F., Xiong, Y., Hla, T., & Maxfield, F. R. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313200 · Cited by 72
Olofsson, S., Wiklund, O., & Borén, J. (2007) · PubMed Central · Cited by 94
Self-citationImmunometabolism of AMPK in insulin resistance and atherosclerosis
Fullerton, M. D., Steinberg, G. R., & Schertzer, J. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.004 · Cited by 77
Bhaskar, S., Kumar, K. S., Krishnan, K., & Helen, A. (2012) · Nutrition · doi:10.1016/j.nut.2012.01.019 · Cited by 74
“Likewise, in a variety of animal models of atherosclerosis, signs of inflammation arise hand in hand with incipient lipid accumulation in the artery wall [3,4].”
BackgroundFormation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins
Panzenboeck, U., & Stocker, R. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.11.003 · Cited by 86
Oxidized phospholipids as triggers of inflammation in atherosclerosis
Leitinger, N. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500086 · Cited by 73
Modification of lipoprotein metabolism and function driving atherogenesis in diabetes
Luciani, L., Pedrelli, M., & Parini, P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117545 · Cited by 72
LDL receptors, caveolae and cholesterol in endothelial dysfunction: oxLDLs accomplices or victims?
Luchetti, F., Crinelli, R., Nasoni, M. G., Benedetti, S., Palma, F., Fraternale, A., & Iuliano, L. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15272 · Cited by 78
“In addition, oxLDLs escape interaction with proteoglycans, which retain LDLs in the extracellular matrix (Skålén et al., 2002), favouring their uptake by macrophage scavenger receptors (Öörni, Pentikäinen, Annila, & Kovanen, 1997).”
BackgroundWilson, P. G., Thompson, J. C., Webb, N. R., de Beer, F. C., King, V. L., & Tannock, L. R. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080201 · Cited by 78
Gisterå, A., Klement, M. L., Polyzos, K. A., Mailer, R. K., Duhlin, A., Karlsson, M. C. I., Ketelhuth, D. F. J., & Hansson, G. K. (2018) · Circulation · doi:10.1161/circulationaha.118.034076 · Cited by 82
A glimpse on the phenomenon of macrophage polarization during atherosclerosis
Pello, Ó. M., Silvestre, C., Pizzol, M. D., & Andrés, V. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.05.010 · Cited by 84
“In both humans and experimental animals, hypercholeserolemia leads to the accumulation of plasmatic lipoproteins into he extracellular matrix of the vessel wall where they undergo xidation (Skalen et al. 2002).”
BackgroundNakagawa, K., & Nakashima, Y. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.03.039 · Cited by 70
DNA methylation processes in atherosclerotic plaque
Aavik, E., Babu, M., & Ylä‐Herttuala, S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.006 · Cited by 83
Kraler, S., Libby, P., Evans, P. C., Akhmedov, A., Schmiady, M. O., Reinehr, M., Camici, G. G., & Lüscher, T. F. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.121.316256 · Cited by 65
Little, P. J., Ballinger, M. L., & Osman, N. (2007) · PubMed Central · Cited by 76
Salicylate improves macrophage cholesterol homeostasis via activation of Ampk
Fullerton, M. D., Ford, R. J., McGregor, C., LeBlond, N. D., Snider, S. A., Stypa, S., Day, E. A., Lhoták, Š., Schertzer, J. D., Austin, R. C., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m058875 · Cited by 75
Fan, Y., Shi, F., Liu, J., Dong, J., Bui, H. H., Peake, D. A., Kuo, M., Cao, G., & Jiang, X. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213363 · Cited by 74
Remnant lipoproteins and atherosclerosis
Twickler, T. B., Dallinga‐Thie, G. M., Chapman, M. J., & Cohn, J. S. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0037-x · Cited by 77
“It is generally believed that upon entry into the intima, TRL remnants can be trapped in a similar fashion to that of LDL (Fig. 2). Local retention of TRL remnants within the intima may occur through ionic interaction of basic amino acids of apoB with negatively charged sulphate groups of the proteoglycan compounds of…”
BackgroundCardiovascular disease in systemic sclerosis
Nordin, A. (2014) · Figshare · Cited by 68
Li, W., Yang, X., Xing, S., Bian, F., Yao, W., Bai, X., Zheng, T., Wu, G., & Jin, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/823071 · Cited by 70
Vascular Extracellular Matrix in Atherosclerosis
Nubila, A. D., Dilella, G., Simone, R., & Barbieri, S. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212017 · Cited by 80
Liu, J., & Rosner, M. H. (2006) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2006.00117.x · Cited by 73
“The mechanisms whereby LDL participates in the atherosclerotic process include retention in the subendothelium of vascular tissues through a charge interaction with extracellular matrix proteoglycans (22), and uptake by macrophages through a scavenger receptor (CD36) to form foam cells (23).”
BackgroundNonhuman Primate Models of Atherosclerosis
Shelton, K. A., Clarkson, T. B., & Kaplan, J. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381366-4.00008-0 · Cited by 67
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
Packard, C. J., Pirillo, A., Tsimikas, S., Ference, B. A., & Catapano, A. L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvad177 · Cited by 61
Cytokine network and T cell immunity in atherosclerosis
Ait‐Oufella, H., Taleb, S., Mallat, Z., & Tedgui, A. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0143-x · Cited by 65
“Initially, lipoproteins infiltrate the artery wall to an extent that exceeds the capacity for elimination and are retained in the intima space [3].”
BackgroundHåversen, L., Sundelin, J. P., Mardinoğlu, A., Rutberg, M., Ståhlman, M., Wilhelmsson, U., Hultén, L. M., Pekny, M., Fogelstrand, P., Bentzon, J. F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34659-2 · Cited by 72
Self-citationThe oxidation ratio of LDL: A Predictor for Coronary Artery Disease
Huang, H., Mai, W., Liu, D., Yuantao, H., Tao, J., & Dong, Y. (2008) · Disease Markers · doi:10.1155/2008/371314 · Cited by 64
“There have been numerous hypotheses trying to explain the correlation of risk factors with the development of atherosclerosis [8–10].”
BackgroundGRANDEALLEN, K., OSMAN, N., BALLINGER, M., DADLANI, H., MARASCO, S., & LITTLE, P. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.014 · Cited by 64
“It has been proposed that therapeutic modifications that reduce the “stickiness” of proteoglycans might mitigate atherosclerosis [10,21].”
BackgroundOtsuka, F., Nakano, M., Ladich, E. R., Kolodgie, F. D., & Virmani, R. (2012) · Thrombosis · doi:10.1155/2012/608593 · Cited by 67
“Fibrin deposition was also frequently higher at sited of high shear as compared to low shear and was only observed in DES (60 [21, 67]% versus 17 [0, 55]%, P = 0.”
BackgroundLi, C., Chen, J. W., Liu, Z. H., Shen, Y. H., Ding, F. H., Gu, G., Liu, J., Qiu, J. P., Gao, J., Zhang, R., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.037 · Cited by 66
Atherosclerosis and Inflammation
Williams, K. J., & Tabas, I. A. (2002) · Science · doi:10.1126/science.297.5581.521 · Cited by 68
Li, W., Yu, J., Zhao, J., Xiao, X., Li, W., Zang, L., Yu, J., Liu, H., & Niu, X. (2020) · Phytotherapy Research · doi:10.1002/ptr.6980 · Cited by 70
“The pathogenesis of AS is closely related to dyslipidemia and inflammatory response (Fahdi, Gaddam, Garza, Romeo, & Mehta, 2003; Skalen et al., 2002).”
BackgroundNonalcoholic fatty liver disease and atherosclerosis
Gaudio, E., Nobili, V., Franchitto, A., Onori, P., & Carpino, G. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0826-5 · Cited by 67
“(LDL) particles in the artery intima represents a key initiating factor in early atherogenesis [19].”
BackgroundLow density lipoprotein misfolding and amyloidogenesis
Parasassi, T., Spirito, M. D., Mei, G., Brunelli, R., Greco, G., Lenzi, L., Maulucci, G., Nicolai, E., Papi, M., Arcòvito, G., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-097774 · Cited by 66
Boekholdt, S. M., Peters, R. J. G., Fountoulaki, K., Kastelein, J. J. P., & Sijbrands, E. J. G. (2003) · Human Genetics · doi:10.1007/s00439-003-0988-3 · Cited by 61
HIV, Inflammation, and Calcium in Atherosclerosis
Shrestha, S., Irvin, M. R., Grünfeld, C., & Arnett, D. K. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302191 · Cited by 69
“Several local proinflammatory cytokines (TNF-α, IL1, IL6, IL12, IL18, IFN-α) are also induced both by HIV replication and lipid-dependent stimuli (eg, infiltration and retention of low-density lipoprotein in the arterial intima).(14,32) Nonstandard Abbreviations and Acronyms”
BackgroundSneck, M., Kovanen, P. T., & Öörni, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508565200 · Cited by 70
Beyond cholesterol: the enigma of atherosclerosis revisited
Lackner, K. J., Han, S., Torzewski, M., Husmann, M., & Bhakdi, S. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-12-0733 · Cited by 63
“Transgenic mice expressing modified apoB that binds poorly to proteoglycans indeed show reduced atheroma development (19).”
BackgroundSchneider, M., Witztum, J. L., Young, S. G., Ludwig, E. H., Miller, E. R., Tsimikas, S., Curtiss, L. K., Marcovina, S. M., Taylor, J. M., Lawn, R. M., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400467-jlr200 · Cited by 61
“Hemizygous mice expressing human apo[a] were crossed with hemizygous mice expressing human apoB-100 only (19, 20), owing to a mutation in codon 2,153 that prevented apoB-48 synthesis (19).”
BackgroundSelf-citationNdisang, J. F., Vannacci, A., & Rastogi, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/506948 · Cited by 68
Systematic Coronary Risk Evaluation (SCORE)
Graham, I. M., Angelantonio, E. D., Visseren, F. L. J., Bacquer, D. D., Ference, B. A., Timmis, A., Halle, M., Vardas, P. E., Huculeci, R., & Cooney, M. T. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.052 · Cited by 69
Nagao, T., Qin, C., Grosheva, I., Maxfield, F. R., & Pierini, L. M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.145086 · Cited by 70
Role of hyaluronan in atherosclerosis: Current knowledge and open questions
Fischer, J. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.003 · Cited by 66
Insights into aortic sclerosis and its relationship with coronary artery disease
Milin, A. C., Vorobiof, G., Aksoy, O., & Ardehali, R. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001111 · Cited by 59
Stiff Substrates Increase Inflammation-Induced Endothelial Monolayer Tension and Permeability
Urbano, R. L., Furia, C. M., Basehore, S. E., & Clyne, A. M. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.06.033 · Cited by 62
Inflammation in atherosclerotic cardiovascular disease
Shah, P. K., & Lecis, D. (2019) · F1000Research · doi:10.12688/f1000research.18901.1 · Cited by 68
Building Multivariate Systems Biology Models
Kirwan, G. M., Johansson, E., Kleemann, R., Verheij, E. R., Wheelock, Å. M., Goto, S., Trygg, J., & Wheelock, C. E. (2012) · Analytical Chemistry · doi:10.1021/ac301269r · Cited by 64
Proteoglycan mediated lipoprotein retention: A mechanism of diabetic atherosclerosis
Tannock, L. R., & King, V. L. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9078-0 · Cited by 63
Olivier, M., Tanck, M. W. T., Out, R., Villard, E. F., Lammers, B., Bouchareychas, L., Frisdal, É., Superville, A., van Berkel, T. J. C., Kastelein, J. J. P., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.243519 · Cited by 72
“Atherosclerotic lesions are characterized by the presence of abundant lipid-laden, macrophage–derived foam cells, which result from the cellular uptake of modified lowdensity lipoprotein and triglyceride-rich lipoproteins (TRL) (mainly very low-density lipoprotein [VLDL] remnants) after infiltration into the arterial…”
BackgroundGisterå, A., Hermansson, A., Strodthoff, D., Klement, M. L., Hedin, U., Fredrikson, G. N., Nilsson, J., Hansson, G. K., & Ketelhuth, D. F. J. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12589 · Cited by 57
Zeng, X., Chen, J., Miller, Y. I., Javaherian, K., & Moulton, K. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500241-jlr200 · Cited by 57
“Biglycan derived from bovine cartilage (Sigma) was used for LDL retention assays as described (9).”
BackgroundMethodInfluentialJones, P. J. H., MacKay, D. S., Senanayake, V. K., Pu, S., Jenkins, D. J. A., Connelly, P. W., Lamarche, B., Couture, P., Kris-Etherton, P. M., West, S. G., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.010 · Cited by 56
Wang, J.-K., Li, Y., Zhao, X.-L., Liu, Y.-B., Tan, J., Xing, Y.-Y., Adi, D., Wang, Y.-T., Fu, Z.-Y., Ma, Y.-T., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.056491 · Cited by 55
Zheng, J., Wang, J., Zhang, Y., Xia, J., Guo, H., Hu, H., Shan, P., & Li, T. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.891929 · Cited by 70
“DALYs are also defined as years of healthy life lost; (3) Summary exposure value (SEV): SEV is the relative risk-weighted prevalence of exposure, setting the scale from 0% when there is no excess risk for a population to 100% when the population is at the highest level of risk.”
BackgroundGetachew, R., Ballinger, M. L., Burch, M. L., Reid, J. J., Khachigian, L. M., Wight, T. N., Little, P. J., & Osman, N. (2010) · Endocrinology · doi:10.1210/en.2010-0027 · Cited by 60
Incidence of the Enterococcal Surface Protein (esp) Gene in Human and Animal Fecal Sources
Whitman, R. L., Przybyla‐Kelly, K., Shively, D. A., & Byappanahalli, M. N. (2007) · Environmental Science & Technology · doi:10.1021/es070817t · Cited by 56
Tran-Lundmark, K., Tran, P.-K., Paulsson-Berne, G., Fridén, V., Soininen, R., Tryggvason, K., Wight, T. N., Kinsella, M. G., Borén, J., & Hedin, U. (2008) · Circulation Research · doi:10.1161/circresaha.107.172833 · Cited by 39
Self-citationLipid accumulation and novel insight into vascular smooth muscle cells in atherosclerosis
Liu, Y., Yuan, P.-Z., Wu, J., & Hu, B. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02109-8 · Cited by 58
Atherosclerosis in perlecan heterozygous mice
Vikramadithyan, R. K., Kako, Y., Chen, G., Hu, Y., Arikawa-Hirasawa, E., Yamada, Y., & Goldberg, I. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400019-jlr200 · Cited by 56
“It has been hypothesized that the interaction of lipoproteins with proteoglycans might differ in mice that express apoE ( 19 ), a stronger proteoglycan binding protein than apoB.”
BackgroundResultInfluentialQuantification of Atherosclerosis in Mice
Centa, M., Ketelhuth, D. F. J., Malin, S., & Gisterå, A. (2019) · Journal of Visualized Experiments · doi:10.3791/59828 · Cited by 48
Leukocyte recruitment in atherosclerosis: Potential targets for therapeutic approaches?
Braunersreuther, V., & Mach, F. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6127-2 · Cited by 67
Increased oxidative stress and altered substrate metabolism in obese children
Oliver, S. R., Duque, J. S. R., Milne, G. L., Pontello, A. M., Borntrager, H. L., Heydari, S., & Galassetti, P. R. (2010) · International Journal of Pediatric Obesity · doi:10.3109/17477160903545163 · Cited by 70
Macrophages and T cells in atherosclerosis: a translational perspective
Bartlett, B., Ludewick, H. P., Misra, A., Lee, S., & Dwivedi, G. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00206.2019 · Cited by 58
Lepedda, A. J., Nieddu, G., Zinellu, E., Muro, P. D., Piredda, F., Guarino, A., Spirito, R., Carta, F., Turrini, F. M., & Formato, M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/385214 · Cited by 56
“The selective retention of circulating apolipoprotein B100 containing lipoproteins in the subendothelial space, by means of specific interactions with artery wall proteoglycans, is currently thought to be the leading event in atherogenesis [3, 4].”
BackgroundZhao, Z.-W., Zhang, M., Chen, L., Gong, D., Xia, X.-D., Yu, X.-H., Wang, S., Ou, X., Dai, X.-Y., Zheng, X., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.04.011 · Cited by 55
Accelerated atherosclerosis in inflammatory rheumatic diseases
Haskard, D. O. (2004) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740410010281 · Cited by 55
“At the initiation of atherogenesis, leaky endothelium is thought to lead to the deposition of low density lipoproteins (LDL) and other atherogenic plasma proteins in the arterial intima, where they bind proteoglycans and are chemically modified by free radicals (64, 65).”
BackgroundResident intimal dendritic cells and the initiation of atherosclerosis
Cybulsky, M. I., & Jongstra‐Bilen, J. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833ded96 · Cited by 67
Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix
Neufeld, E. B., Zadrozny, L. M., Phillips, D., Aponte, A., Yu, Z.-X., & Balaban, R. S. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.038 · Cited by 51
“What might be the best target for interfering with the electrostatic interaction between LDL lysines and the decorin and biglycan glycans in disease-prone cardiovascular sites? In vivo validation for this therapeutic approach has in part been provided by studies which showed that mutations in the proteoglycan binding…”
Stöhr, R., & Federici, M. (2013) · Biochemical Journal · doi:10.1042/bj20130121 · Cited by 58
Myeloid Tribbles 1 induces early atherosclerosis via enhanced foam cell expansion
Johnston, J. M., Angyal, A., Bauer, R. C., Hamby, S. E., Suvarna, S. K., Baidžajevas, K., Hegedus, Z., Dear, T. N., Turner, M., Wilson, H. L., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax9183 · Cited by 54
“In the early-stage 72 atherosclerotic plaque this transformation is induced by the uptake of both LDL-C and oxidized 73 (ox)LDL (2, 4), which may serve a beneficial purpose (3); but unrestrained, the crucial function of 74 plaque-macrophages in resolving local inflammation is compromised and the development of 75 unst…”
BackgroundViola, M., Bartolini, B., Vigetti, D., Karousou, E. G., Moretto, P., Deleonibus, S., Sawamura, T., Wight, T. N., Hascall, V. C., Luca, G. D., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.508341 · Cited by 60
“LDL retention at the subendothelial level is one of the first events triggering atherosclerosis, with the concurrent involvement of SMC for the disease onset and progression (20, 41).”
BackgroundChait, A. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.02.010 · Cited by 58
Banfi, C., Brioschi, M., Barcella, S., Wait, R., Begum, S., Galli, S., Rizzi, A., & Tremoli, E. (2009) · PROTEOMICS · doi:10.1002/pmic.200800566 · Cited by 55
“ApoB-100 binds to arterial wall proteoglycans, promoting subendothelial retention of atherogenic low-density lipoprotein (LDL) in early atherosclerosis [3].”
BackgroundXu, Y., Zhu, W., Wang, T., Jin, L., Liu, T., Li, X., Guan, Z., Jiang, Z., Meng, X., Wang, J., et al. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.10.097 · Cited by 49
Nanoscale Anionic Macromolecules Can Inhibit Cellular Uptake of Differentially Oxidized LDL
Chnari, E., Nikitczuk, J. S., Uhrich, K. E., & Moghe, P. V. (2006) · Biomacromolecules · doi:10.1021/bm0506905 · Cited by 48
Modified Lipoprotein-Derived Lipid Particles Accumulate in Human Stenotic Aortic Valves
Lehti, S., Käkelä, R., Hörkkö, S., Kummu, O., Helske-Suihko, S., Kupari, M., Werkkala, K., Kovanen, P. T., & Öörni, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065810 · Cited by 49
“In atherosclerosis, the cause of lipid accumulation is considered to be the binding and entrapment of plasma lipoproteins by the components of the arterial extracellular matrix, particularly proteoglycans [40,41,42,43,44,45].”
Alcohol inflammation and coronary heart disease
Imhof, A., & Köenig, W. (2003) · Addiction Biology · doi:10.1080/13556210310001602176 · Cited by 59
“meability for lipoproteins and other plasma components.(40,41) In vitro, modified lipoproteins such as oxidized low density lipoproteins (LDL)”
BackgroundAnggraeni, V. Y., Emoto, N., Yagi, K., Mayasari, D. S., Nakayama, K., Izumikawa, T., Kitagawa, H., & Hirata, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.096 · Cited by 53
Fredrikson, G. N., Hedblad, B., Berglund, G. L., Alm, R., Nilsson, J., Șchiopu, A., Shah, P. K., & Nilsson, J. Å. (2007) · Stroke · doi:10.1161/strokeaha.106.474577 · Cited by 47
Grandoch, M., Kohlmorgen, C., Melchior‐Becker, A., Feldmann, K., Homann, S., Müller, J., Kiene, L. S., Zeng-Brouwers, J., Schmitz, F., Nagy, N., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306973 · Cited by 54
Cathepsin G activity lowers plasma LDL and reduces atherosclerosis
Wang, J., Sjöberg, S., Tang, T.-T., Öörni, K., Wu, W., Liu, C., Secco, B., Tia, V., Sukhova, G. K., Fernandes, C., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.026 · Cited by 48
“Subendothelial retention of LDL by binding to intimal proteoglycan occurs during atherogenesis [53], and ECs from human atherosclerotic lesions contain CatG (Fig.”
BackgroundPlaque-Stabilizing Effect of Pitavastatin in Watanabe Heritable Hyperlipidemic(WHHL) Rabbits.
Suzuki, H., Hideyuki, K., Sato, F., Yonemitsu, Y., Nakashima, Y., & Sueishi, K. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.109 · Cited by 51
The role of immune cells in different stages of atherosclerosis
He, C., Kim, H. I., Park, J. B., Guo, J., & Huang, W. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.94570 · Cited by 50
“Infiltrated low-density lipoprotein (LDL) can activate endothelial cells, and subsequently induce the recruitment of monocytes (3).”
BackgroundVulnerable atherosclerotic plaque - a review of current concepts and advanced imaging
Špaček, M., Zemánek, D., Hutyra, M., Sluka, M., & Táborský, M. (2018) · Biomedical Papers · doi:10.5507/bp.2018.004 · Cited by 49
Adipophilin Expression Is Increased in Symptomatic Carotid Atherosclerosis
Nuotio, K., Sorto, P., Saksi, J., Ijäs, P. H., Pitkäniemi, J. M., Sonninen, R., Soinne, L., Saimanen, E. I. T., Salonen, O. L. M., Kovanen, P. T., et al. (2007) · Stroke · doi:10.1161/strokeaha.106.478867 · Cited by 46
Increased atherosclerosis in mice with increased vascular biglycan content
Thompson, J. C., Tang, T., Wilson, P. G., Yoder, M. H., & Tannock, L. R. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.03.037 · Cited by 45
Role of Oxidized LDL in Atherosclerosis
Leiva, E., Wehinger, S., Guzmán, L., & Orrego, R. (2015) · InTech eBooks · doi:10.5772/59375 · Cited by 62
“OxLDL has also been shown to induce changes directly in SMCs. OxLDL increases migration and leads to changes in SMCs phenotype making them to produce large amounts of ECM [72].”
BackgroundInfluentialMetformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective
Romualdi, D., Costantini, B., Selvaggi, L., Giuliani, M., Cristello, F., Macrì, F., Bompiani, A., Lanzone, A., & Guido, M. (2008) · Human Reproduction · doi:10.1093/humrep/den230 · Cited by 49
Ahmed, O., Littmann, K., Gustafsson, U. O., Pramfalk, C., Öörni, K., Larsson, L., Minniti, M. E., Sahlin, S., Camejo, G., Parini, P., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009876 · Cited by 48
Metadata
- Authors
- Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J.
- Affiliations
- University of Gothenburg (SE)
- Gladstone Institutes (US)
- Corresponding author
- Borén, Jan
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6890
- Pages
- 750-754
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083154566
- Cited by
- 1,019
- References
- 28
- Citations by year
- 2026: 23 · 2025: 28 · 2024: 38 · 2023: 42 · 2022: 41 · 2021: 69 · 2020: 48 · 2019: 39 · 2018: 39 · 2017: 29 · 2016: 27 · 2015: 46 · 2014: 42 · 2013: 42 · 2012: 63
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Heart Association
- Research to Prevent Blindness
- Vetenskapsrådet
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, atherogenesis, apolipoprotein B, apolipoprotein B-100, low-density lipoprotein, proteoglycans, extracellular matrix, sulfate groups, transgenic mice, atherogenic lipoproteins
- MeSH terms
- Animals, Aorta, Apolipoproteins B, Arteriosclerosis, Binding, Competitive, Cholesterol, Diet, Atherogenic, Endothelium, Vascular, Female, Humans, Lipoproteins, Lipoproteins, LDL, Macrophages, Mice, Transgenic, Models, Biological, Mutation, Receptors, LDL, Recombinant Proteins, Triglycerides, Tumor Necrosis Factor-alpha, Amino Acid Substitution, Mice, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.